Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

4:30 PM - 4:35 PM PT

1065 - Patient Reported Outcomes following Accelerated Partial Breast vs. Ultrahypofractionated/Hypofractionated Whole Breast: A Single Institution Comparison Study
Speaker: Rau, Allison, MD, MS - Arthur JE Child Comprehensive Cancer Centre, Calgary, AB
4:30 PM - 4:35 PM PT

1077 - A Dynamic Treatment Strategy for Oligometastatic CSPC: Integrating Molecular Imaging and SBRT to Personalize Systemic Therapy Intensification and De-Intensification
Speaker: Bettoli, Piero, MD - Universidad de Los Andes, LAS CONDES, Región Metropoli
4:30 PM - 4:40 PM PT

344 - Nimotuzumab Plus Concurrent Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma: Updated Follow-up from the Randomized, Phase 3 CC3 Study
Speaker: Wang, Junjie, MD - Peking University Third Hospital, Beijing
4:30 PM - 4:40 PM PT

349 - Epicardial Fat as a Radiomic Predictor of Cardiac Outcomes Following Thoracic Radiotherapy for Lung Cancer
Speaker: Jiao, Qiao, MS, BS, BA - Harvard Medical School, Boston, MI
4:35 PM - 4:45 PM PT

1069 - Characterization of Glioblastoma Infiltration and Survival by Brain Regions
Speaker: Yeo, Wan-Jin, PhD - University of California, San Francisco, San Francisco, CA
4:40 PM - 4:50 PM PT

345 - The Endoscopy Results of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-Induced Acute Rectal Injury: A Multi-Center,
Speaker: Zhu, Jiawei, MD - Peking Union Medical College Hospital, Beijing, Beijing
4:40 PM - 4:50 PM PT

350 - Dosimetric Parameters of the Heart and its Substructures Predicting Survival and Cardiac Events in Lung Cancer Patients after Radiotherapy: A Systematic Review and Meta-Analysis
Speaker: Wang, Jun, MD, PhD - The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
4:45 PM - 4:55 PM PT

1070 - Induction-Concurrent Chemoradiotherapy with or without Camrelizumab for Postoperative Residual High-Grade Gliomas: An Open, Randomized, Phase II Clinical Study
Speaker: Huang, Guiying - The Affiliated Cancer Hospital of Guizhou Medical University, Guizhou Province, Guizhou Province
4:50 PM - 5:00 PM PT

Discussant
Speaker: Chino, Junzo, MD, FASTRO - Duke Cancer Institute, Durham, NC
4:50 PM - 5:00 PM PT

Discussant
Speaker: Rodrigues, George, MD, PhD, FASTRO - London Health Sciences Centre, London, ON
4:55 PM - 5:05 PM PT

1071 - A Prospective Study to Evaluate the Impact of Radiotherapy Technique - 3DCRT vs. Hippocampal Sparing Volumetric Modulated Arc Therapy (hsVMAT) - on Neurocognitive Function (NCF) in Adults with Grade 2
Speaker: Goyal, Shikha, MD - Medanta The Medicity, Gurgaon, Haryana
5:15 PM - 6:15 PM PT

GU 8: Quick Pitch: Novel Concepts in Localized Prostate Cancer
Speaker: Zaorsky, Nicholas, MD, MS - University Hospitals, Cleveland, Ohio